Effect of reduced dose of long-acting GnRH agonist versus short acting GnRH agonist
Phase 3
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT20190609043845N1
- Lead Sponsor
- Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 400
Inclusion Criteria
Age = 40 years
Basal FSH level <8
Less than one failed ICSI cycle
Non PCOS patients
No azoospermia
No moderate to severe endometriosis
Exclusion Criteria
No response to ovulation induction
Difficult embryo transfer
Bloody embryo transfer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical pregnancy rate. Timepoint: Two month after intervention. Method of measurement: Positive ßhCG test (Lab kit).;Clinical pregnancy rate. Timepoint: Two month after intervention. Method of measurement: Assessment of gestational sac and fetal heartbeat at 7 weeks of gestation (Vaginal ultrasonography).
- Secondary Outcome Measures
Name Time Method Gonadotropin dosage. Timepoint: At the end of ovarian induction cycle. Method of measurement: Total number of ampoule.;Duration of ovarian induction. Timepoint: At the end of ovarian induction cycle. Method of measurement: Number of days.